30 C
Vientiane
Saturday, May 24, 2025
spot_img
Home Blog Page 2072

SATA CommHealth’s Osteoporosis and Fall Prevention Festival Returns with First In-Person Edition

SINGAPORE – Media OutReach – 10 November 2022 – SATA CommHealth, in collaboration with Kampong Chai Chee AAC/SCEC, is pleased to announce the second edition of the Osteoporosis and Fall Prevention Festival 2022, which will be happening from 18 to 20 November 2022. Held in person for the very first time at Heartbeat @ Bedok, the festival aims to improve the lives of seniors and caregivers through proper awareness and education. The three-day event will be officially opened by Guest of Honour, Mr. Tan Kiat How – Senior Minister of State, Ministry of Communication and Information, Ministry of National Development and Adviser to East Coast GRC GROs, on the 19 November 2022.

Campaign-Image.jpg

Osteoporosis and Fall Prevention Festival 2022

Themed “Building Strong Bones”, the festival will feature talks, presentations, and workshops focusing on the foundations of building strong bones, fall prevention in the community, and how technology can improve bone strength, especially among the silver generation. There will also be sharing sessions hosted by an esteemed panel of speakers consisting of orthopaedic specialists, therapists, dietitians, community leaders, and technology experts who will provide in-depth knowledge on how best to prevent falls.

According to the National Library of Medicine, Singapore has one of the highest reported hip fractures in Asia, with one in three women above 50 years old suffering from Osteoporosis. The projected annual number is also expected to hit 5,000 cases by 2050. In addition, the International Osteoporosis Foundation reported that approximately 8,000 seniors aged 65 and above were admitted to restructured hospitals from 2013 to 2016 due to falls. 33% of these cases became fully dependent or were admitted into nursing homes. 40% of injury-related deaths in Singapore have also been linked to falls.

With greater awareness, reduced risk factors, and clinical interventions, falls among seniors can be significantly reduced. As part of the festival, visitors can expect to learn more about topics such as preventing falls at home, nutrition, and diet to complement movement, and the use of technologies such as ankle foot orthosis and electrical stimulation for walking, to decrease the chances of a fall.

Edmund Khoo, Chairman of the Osteoporosis and Fall Prevention Festival Committee, commented, “With Singapore progressively becoming an ageing population, SATA CommHealth wants to offer Singaporeans the opportunity to learn more about Osteoporosis and fall prevention through the varied platforms such as clinical intervention, assessments, exercises, and the use of technology. We hope this festival can shed some light on how one can help themselves or their loved ones take preventive measures to avoid fatal falls.”

The Osteoporosis and Fall Prevention festival was born out of the Osteoporosis and Fall Prevention programme offered to seniors at the day rehabilitation centre. It is one of many programmes that SATA CommHealth spearheads as part of its vision to promote lifelong health within the community. Having been in service for 75 years, SATA CommHealth provides accessible healthcare through their home and centre-based services. This includes Doctors-On-Wheels, Homecare and Rehabilitation services, and the Community Hub @ Fernvale.The charity also works with community clubs, grassroots organisations, voluntary welfare partners, and religious and special interests groups to provide screenings and treatments for beneficiaries and staff, with the aim of doing more for the seniors and vulnerable groups to build a healthy community.

The Osteoporosis and Fall Prevention Festival 2022 will be happening from 18 to 20 November 2022. For more information and to sign-up for the festival programmes, please visit https://bit.ly/3DQ2482.

Hashtag: #SATACommHealth

About SATA CommHealth

SATA CommHealth is a registered charity organisation in Singapore and an established medical healthcare provider. Established in 1947, SATA CommHealth was initially formed to support the government in containing the Tuberculosis outbreak. Today, 75 years on, SATA CommHealth serves more than 200,000 people across six medical centres islandwide and remains the leading provider of statutory health screening that actively provides community healthcare to the general public.

SATA CommHealth’s primary community programmes and services include Doctor Consultation Services, Medical Diagnostic Imaging Services, Preventive Health Screening, Statutory Health Screening, Mobile Medical Services and Telemedicine. SATA CommHealth also runs other charitable programmes like Doctors-On-Wheels, Homecare Services, Day Rehabilitation Centres, Community Hub in Fernvale and Health Talks for corporate companies.

For more information, visit

Top UK university welcomes talented international students as demand for health and life sciences booms

NORWICH, UK – Media OutReach – 9 November 2022 – The University of East Anglia (UEA) – the United Kingdom’s Top 30 university known for its world-leading research – is actively looking for talented international students in the fields of health and life sciences to study at its 360-acre campus in Norwich.

As countries worldwide come to terms with the long-term health effects of ageing populations, the demand from international students for top-quality health care courses at UK universities is increasing year on year. From 2019 to 2021 Nursing and Adult Nursing has witnessed a 75% uptick, Counselling, Psychotherapy and Occupational Therapy 60%, and Physiotherapy 25%.

INTO UEA – UEA’s on-campus international education partner – is offering an International Foundation in Pharmacy, Health and Life Sciences that provides students from across the globe with the opportunity to progress to over 60 courses at UEA.

With UEA’s Medicine, Pharmacy and Pharmacology, Occupational Therapy, and Physiotherapy courses all ranked within the top 15 in their subject areas in the UK, INTO UEA is a perfect springboard for tomorrow’s top health professionals.

Marco from Hong Kong completed his Foundation programme at INTO UEA in 2019 and graduated from UEA in 2022 with a 1st in BSc Physiotherapy. He says: “My physiotherapy course provided me with a compulsory placement experience in hospital, allowing me to get practice and experience for my future working environment.”

Kaley, also from Hong Kong, completed her Foundation course at INTO UEA in 2017, progressed to UEA and achieved a 1st in BSc Occupational Therapy before completing an MSc in Clinical Research. She says: “I completed six placements throughout my degree, equating to over 1200 hours of work. This equipped me with the knowledge and skills needed to become a confident newly-qualified Occupational Therapist.”

INTO UEA’s on-campus centre offers academic preparation courses and English language programmes designed specifically for international students. With a sharp focus on student success, the courses prepare international students for entry to UK universities.

Dawn Wilkinson, Programme Manager at INTO UEA, says: “Studying at INTO UEA means being at the heart of bioscience research, discovery and real-world innovation. UEA is an integral member of Norwich Research Park, Europe’s leading hub of bioscience researchers working together to solve real-world problems in health, food and the environment. Our students benefit from top-class teaching, facilities and opportunities to get involved.”

“INTO UEA’s highly experienced team has outstanding success rates in helping students successfully gain places on competitive medicine and health science degree courses, through extensive personalised support.”

UEA is ranked in the UK top 20 for research quality and UK top 25 in the Graduate Outcomes Survey.

Hashtag: #INTOUniversityPartnerships

About INTO University Partnerships:

INTO University Partnerships connects students seeking quality international education with leading universities in the UK, US and Australia. Since its inception in 2005, INTO has helped more than 130,000 students from 190 countries realise their dream of achieving a degree from a world-class university.

Johnson Electric reports results for the half year ended 30 September 2022

Highlights of FY22/23 Half-Year Results

  • Group sales US$1,770 million – up 6% compared to first half of the prior financial year. Excluding the effects of foreign currency movements and an acquisition, sales increased by 11%
  • Gross profit US$355 million or 20.0% of sales (compared to US$357 million or 21.3% of sales in first half of the prior financial year)
  • Adjusted EBITA US$111 million (compared to US$138 million in first half of the prior financial year)
  • Net profit attributable to shareholders decreased by 40% to US$56 million or 6.21 US cents per share on a fully diluted basis
  • Net profit excluding non-cash foreign exchange rate movements and restructuring costs, decreased by 19% to US$78 million
  • Free cash flow from operations US$80 million (compared to a free cash outflow of US$56 million in first half of the prior financial year)
  • Total debt to capital ratio of 17% and cash reserves of US$298 million as of 30 September 2022
  • Interim dividend 17 HK cents per share (2.18 US cents per share) with a scrip dividend alternative

HONG KONG SAR – Media OutReach – 9 November 2022 – Johnson Electric Holdings Limited (“Johnson Electric”), a global leader in electric motors and motion subsystems, today announced its results for the six months ended 30 September 2022.

Total Group sales for the first half of FY22/23 totalled US$1,770 million, an increase of 6% over the first half of the prior financial year. Excluding the effects of foreign currency movements and an acquisition, sales increased by 11%. Net profit attributable to shareholders decreased by 40% to US$56 million or 6.21 US cents per share on a fully diluted basis. Net profit, after adjusting for the effects of non-cash foreign exchange rate movements and restructuring costs, decreased by 19% to US$78 million.

Automotive Products Group

The Automotive Products Group (“APG”), which accounted for 79% of total Group sales in the period under review, reported a 16% increase in sales on a constant currency basis. This robust growth rate, which comfortably exceeded global auto industry production volume growth over the same period, reflected the division’s focus on technology solutions that are enabling the industry’s shift to increased electrification, reduced emissions, and improved safety and comfort.

The global auto industry is presently experiencing its greatest upheaval in decades as a result of the combination of near-term supply chain constraints, the structural shift away from the internal combustion engine to electric propulsion, and increasing macro-economic headwinds. Although the recent global shortages of semiconductors have shown some signs of improvement, this critical supply bottleneck is continuing to have a highly disruptive impact on OEM production schedules for specific vehicle models that then cause knock-on disruptions and production inefficiencies for component suppliers.

On a geographic basis, APG grew sales in constant currency terms in each of its three major regional markets. However, the operating conditions and factors currently influencing end-market demand in these markets are starkly different.

In the Americas, APG’s sales increased by 23% on a constant currency basis. As a result of supply constraints and pent-up consumer demand for new vehicles, US light vehicle inventories remain at below-average levels and the average retail price of a car has risen sharply to more than US$48,000 (and currently stands at US$65,000 for an electric vehicle). In Europe, although OEMs were also able to command higher retail prices for their most sought-after models, operating conditions were extremely challenging due to ongoing components shortages, high inflation, and growing concerns among both consumers and producers over the severe energy crisis triggered by the war in Ukraine. In this context, APG Europe performed creditably with constant currency sales growth of 8% – though it should be noted that due to the strength of the US Dollar against the Euro during the period, APG Europe’s reported sales in US Dollars declined by 3%. Finally, in China, end-market demand continues to be highly influenced by government policies. In the second quarter of the 2022 calendar year, car sales plunged due to Covid-related lockdowns. Sales demand subsequently recovered, due in part to tax incentives to purchase new energy vehicles, but remained relatively soft as Covid-related restrictions have continued and economic conditions have deteriorated. APG’s sales in Asia, the majority of which are to China, nonetheless increased by 17% in constant currency terms.

Industry Products Group

The Industry Products Group (“IPG”), which accounted for 21% of total Group sales, reported a 5% decrease in sales on a constant currency basis compared to the first half of the prior year.

At the height of the pandemic, IPG experienced exceptionally strong demand growth as consumer expenditure shifted disproportionately away from services and towards goods (especially “home-centric” goods). During the course of 2022, as pandemic restrictions began to lift in North America and Europe, there has been a gradual normalization of consumer expenditure patterns which has seen a number of IPG’s end customers and contract manufacturers move to reduce their excess inventory levels and cut back on orders. The second factor leading to reduced demand in some product areas is heightened concerns among consumers about inflation and the growing risk of a recession in many developed economies.

Notwithstanding the increasing macro-economic headwinds, IPG continued to make encouraging progress in growing its share in several high-growth market application segments, including medical devices, ventilation, window automation, and semiconductor manufacturing equipment.

Profitability and Financial Condition

Gross profit decreased by 1% to US$355 million – which as a percentage of sales represented a decline from 21.3% to 20.0%. The decline in gross margins was largely the result of higher raw material expenditure and reduced gains on foreign currency hedging contracts, which were only partially offset by pricing adjustments, volume increases and cost-reduction initiatives.

Group operating profits amounted to US$69 million compared to US$117 million in the first half of the prior financial year. The reduction in reported operating income was primarily due to a loss of US$7 million derived from Other Income and Expenses, compared to a profit of US$30 million in the prior half year. This reversal was mainly due to unrealized foreign exchange rate losses resulting from the strength in the US Dollar and also the absence of a fair value gain on the Group’s investment in an autonomous driving technology business that was recorded in the prior year.

Excluding costs related to the restructuring of the Group’s manufacturing footprint and non-cash items related to foreign currency movements, the net profit margin for the first half decreased to 4.4% compared to 5.8% in the first half of the prior financial year.

Johnson Electric’s financial condition remains sound with a total debt to capital ratio of 17% and cash balances of US$298 million as of 30 September 2022.

Interim Dividend

The Board has today declared an interim dividend of 17 HK cents per share, equivalent to 2.18 US cents per share (2021/22 interim: 17 HK cents per share). The interim dividend will be payable in cash with a scrip alternative where a 4% discount on the subscription price will be offered to shareholders who elect to subscribe for shares. The Board has further been informed that the controlling shareholder of the Company intends to subscribe for its entire eligible allocation of shares under the scrip dividend alternative. Full details of the scrip dividend alternative will be set out in a circular to shareholders.

The interim dividend will be payable on 18 January 2023 to shareholders registered on 6 December 2022.

Corporate Development and Acquisitions

In September 2022, the Group acquired the remaining 20% equity interest it did not already own in Halla Stackpole Corporation, an Asia-focused powder metallurgy business with a strong presence in China and Korea. On becoming a wholly-owned subsidiary of the Group, the business is being further integrated into the Stackpole Powder Metal business unit to realize additional operating synergies. As the automotive market transitions to electric vehicles, lighter-weight components produced using powder metal technology are expected to play an increasingly important role in delivering greater energy efficiency and improved performance compared to conventional forged or die cast metal counterparts.

In October 2022, after the closing of the financial statements for the first half, the Group also completed the acquisition of an 80% equity stake in Pendix GmbH, an established, technology-driven player in the fast-growing electric bike (“e-bike”) sector. Based in Zwickau, Germany, Pendix designs, manufactures, and brings to market complete electric cargo bikes and electric drives for bicycles. By combining Pendix’s technology and application expertise with Johnson Electric’s industrial scale and resources, the acquisition provides an exciting platform from which to build a strong and differentiated presence in the European e-bike market.

Chairman’s Comments on the Half-Year Results and Outlook

Commenting on the results, Dr. Patrick Wang, Chairman and Chief Executive, said, “Johnson Electric’s financial performance in the six-month period ended 30 September 2022 was mixed. Sales grew at a healthy double-digit rate in constant currency terms despite ongoing supply constraints and increasing economic uncertainty in several end markets. At the same time, the exceptional strength of the US Dollar compared to other major currencies had a negative impact on both reported sales and operating margins. Combined with higher raw material costs and other operating cost increases, this resulted in significantly reduced earnings attributable to shareholders during the period.”

“With inflation in much of the world at a four-decade high, Europe’s economies shaken by an energy crisis and a war, and China persisting with highly-restrictive pandemic control measures, it is difficult not to foresee a challenging near-term outlook for global manufacturing businesses.”

“As noted earlier, the impact of weaker consumer confidence has already been felt in several of IPG’s product applications and is necessitating a review of costs and a reduction in capital investment in some segments. In the North American and European automotive sectors, the supply chain constraints that have dominated the industry in recent months can be expected to gradually improve, but end-customer demand may also begin to soften as interest rates rise and consumers turn increasingly cautious. The near-term outlook for China’s automotive sector will more likely hinge largely on whether the government adopts new policies to address the pandemic and stabilize the property market. APG’s business unit management is thus prioritizing cash generation, cost containment, and accelerating the rationalization of some product lines based on strict return on capital criteria.”

“A deteriorating macro-economic environment is not new territory for Johnson Electric and the business has a number of fundamental strengths that have enabled us to navigate our way through past recessions and market disruptions successfully. These include, firstly, recognized market leadership across a broad range of motion technologies that are critical enablers for increased electrification, lower emissions, improved safety, and greater controllability. Second, we serve a large and diverse customer base that is relatively evenly distributed across the three major economic regions. Third, the Group’s operating footprint has continued to expand and evolve to ensure that those customers can always rely on Johnson Electric for its speed of response and security of supply. And fourth, we have long track record of disciplined financial management.”

Dr. Patrick Wang further commented, “Therefore, looking beyond the near-term uncertainties, shareholders should feel confident that the Company remains soundly positioned to grow share and improve profitability in a widening range of high-growth applications for innovative motion technologies.”

Hashtag: #JohnsonElectric

The issuer is solely responsible for the content of this announcement.

About Johnson Electric Group

The Johnson Electric Group is a global leader in electric motors, actuators, motion subsystems and related electro-mechanical components. It serves a broad range of industries including Automotive, Smart Metering, Medical Devices, Business Equipment, Home Automation, Ventilation, White Goods, Power Tools, and Lawn & Garden Equipment. The Group is headquartered in Hong Kong and employs over 35,000 individuals in 22 countries worldwide. Johnson Electric Holdings Limited is listed on The Stock Exchange of Hong Kong Limited (Stock Code: 179). For further information, please visit: .

Forward Looking Statements

This news release contains certain forward looking statements with respect to the financial condition, results of operations and business of Johnson Electric and certain plans and objectives of the management of Johnson Electric.

Words such as “outlook”, “expects”, “anticipates”, “intends”, “plans”, “believe”, “estimates”, “projects”, variations of such words and similar expressions are intended to identify such forward looking statements. Such forward looking statements involve known and unknown risk, uncertainties and other factors which may cause the actual results or performance of Johnson Electric to be materially different from any future results or performance expressed or implied by such forward looking statements. Such forward looking statements are based on numerous assumptions regarding Johnson Electric’s present and future business strategies and the political and economic environment in which Johnson Electric will operate in the future.

Yingli Pharma Announces NMPA Approval of New Anti-cancer Drug Linperlisib

The first highly selective PI3Kδ inhibitor in China

SHANGHAI, CHINA Media OutReach 9 November 2022Shanghai Yingli Pharmaceutical Co., Ltd. (the “Company” or “Yingli Pharma“) is pleased to announce that linperlisib, trade name因他瑞®, a novel phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, has been approved by the National Medical Products Administration (NMPA) of China on November 9 for the treatment of relapsed/refractory follicular lymphoma (R/R FL) in patients who have received 2 or more prior systemic therapies. The NDA approval validates Yingli Pharma’s strong innovation capabilities and fulfills the company’s objectives to bring new treatment options to patients and their families.

Picture-12.png

[Photo: NMPA Approval of linperlisib]

Yingli Pharma has entered into strategic partnership with Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a leading pharmaceutical company with well-established oncology sales and marketing network, to commercialize因他瑞® in China.

A safe and effective treatment choice for FL patients

Linperlisib is a next generation phosphoinositide 3-kinase delta (PI3Kδ) inhibitor independently developed by the Company. PI3Kδ plays a key role in the tumor immune cell proliferation and survival, making it a potent target for non-Hodgkins lymphomas. Treatment options for R/R FL patients, a major form of non-Hodgkins lymphoma, are extremely limited in China. In 2020, linperlisib was awarded NMPA Breakthrough Therapy status for the treatment of R/R FL in China. In addition, it received U.S. Food and Drug Administration (FDA) Orphan Drug Designations for FL, Chronic lymphocytic leukemia/ small lymphocytic lymphoma and T cell lymphoma.

In the pivotal R/R FL Phase II clinical trial in China, linperlisib-treated patients had an 79.8% overall response rate, a 96.6% disease control rate, a median Time to Response of 1.9 months, a median Progression Free Survival of 13.4 months, Duration of Response of 12.3 months and a 91.4% overall survival rate at 12 months1. Linperlisib was well-tolerated with a differentiated and manageable safety profile, with low immune-mediated toxicities. In the linperlisib-treated patient safety dataset of the pivotal study, the most common (>15%) non-hematologic treatment related adverse events (TRAE) (Any Grade/ Grade3) were hypertriglyceridemia (25%/3%), ALT elevation (19%/2%), AST elevation (15%/2%), diarrhea (15%/2%), and pneumonia (15%/15%). The most common (>5%) hematologic TRAEs (Grade3) were neutropenia (15%), leukocytopenia (5%), and lymphocytopenia (5%).

“We are pleased to provide a new treatment option for patients with R/R FL with the approval of linperlisib. As linperlisib is the first innovative drug independently developed by Yingli Pharma, the NDA approval is a significant milestone”, said Dr. Xu Zusheng, General Manager and President of R&D of Yingli Pharma, “We would like to thank the patients, clinicians, and scientists for their generosity and great effort in the clinical development of linperlisib. It is a convenient once daily oral drug which demonstrated favorable safety, promising efficacy and great patient compliance. Yingli Pharma looks forward to in-depth collaboration with Hengrui Pharma to bring forth a full commercialization of 因他瑞® and extend the clinical development into additional indications.”

Dr. Lianshan Zhang, Deputy General Manager and President of Global R&D of Hengrui Pharma, said, ” We are delighted with the NDA approval of linperlisib (因他瑞) for R/R FL. This approval is an important step for Hengrui Pharm to build a strong hematology franchise with an enriched pipeline. As Hengrui Pharma focuses on patient-centered R&D and innovation, we will continue to evaluate new indications for linperlisib, and combinations with the company’s existing products to potentially benefit more patients.”

1. Lugui Qiu et al. 2022EHA.Abstract 1119

Hashtag: #YingliPharma

About Yingli Pharma

Shanghai Yingli Pharmaceutical Co., Ltd. is a technologically innovative biopharmaceutical company founded in 2011 and located in the National Biomedical Industry Base of Shanghai Zhangjiang InnoPark. With the Chinese government promotion of healthcare reforms, the Chinese pharmaceutical industry has gradually transformed to include the biopharmaceutical sector of innovation. The NDA approval of linperlisib is a significant milestone for this national effort and demonstrates the Company’s strong innovation capability for drug development. Yingli Pharma has established a rich and independently-developed pipeline of novel oral agents for oncology and metabolic diseases. The Company has more than ten drugs under development, including more than 100 independent intellectual property rights, with three of the investigational agents in clinical stage in China and abroad.

For more information, please see:

Laos is One of National Geographic’s Top Five Spots for Slow Travel in 2023

Image by wirestock on Freepik

After selecting Laos as one of the 25 most breathtaking places one should visit in 2023, the popular magazine has curated a new list that features the country once again.

The Société Royale d’Encouragement du Cheval (SOREC) organizes the 8th edition of the Morocco International Meeting of horse racing (MIM), November 19th and 20th, at Casablanca-Anfa Racecourse

This major event welcomes a list of prestigious Moroccan and international participants

CASABLANCA, MOROCCO – EQS Newswire – 9 November 2022 – The Société Royale d’Encouragement du Cheval (SOREC) (https://www.SOREC.ma) will host the 8th edition of the Morocco International Meeting (MIM), an event organized annually on the third weekend of November.

This major event welcomes a list of prestigious Moroccan and international participants. SOREC has mobilized the best resources to organize this event in accordance with the international standards, as it continues its mission to strengthen the role of MIM in promoting Moroccan horse racing.

Our major objective is to raise awareness about Moroccan horse racing on the international scene. We are particularly happy to be able, once again, to welcome the international horse racing community. Their trust in the Kingdom’s horse racing industry, as well as their interest in the Morocco International Meeting, have strongly contributed to positioning this event among the most important stages of the racing international calendar,” says Mr. Omar Skalli, CEO of SOREC.

An international program

The Morocco International Meeting program will feature 14 races—including 8 international races—with a total prize money of €750.000. The first day will be dedicated to Thoroughbreds and the second to Purebred Arabians.

The highlight races of the weekend will be the Grand Prix of His Majesty The King Mohammed VI for Purebred Arabians and for Thoroughbreds.

Purebred Arabian Day will offer three additional major prizes:

  • Grand Prix HRH The Crown Prince Moulay El Hassan;
  • Grand Prix HRH The Prince Moulay Rachid;
  • Prix The UAE President Cup.

Thoroughbred Day will host the Grand Prix SOREC, part of the prestigious international competition series “Défi du Galop”.

Optimal benefits for participants

SOREC will provide international participants with significant support, notably for the transportation of horses and a complete welcome program.

Hashtag: #SOREC

About SOREC

The Société Royale d’Encouragement du Cheval (SOREC) was created in 2003 as a public company under the supervision of the Ministry of Agriculture, Fisheries, Rural Development, Water and Forests. SOREC has established a unique business model on the global scene, pursuing multiple missions: Breeding supervision and improvement in the National Stud farms, Horse racing management, betting management; and the construction and operation of horse racing infrastructures. SOREC strives to positioning the equine sector as a driving force for development in rural areas, directing actions to promote breeds and monetize the role of horses to support the emergence of ecosystems that are economically viable and financially independent.

That Luang Festival Returns to its Pre-Pandemic Glory This Year

An aerial shot of the That Luang stupa captured during the festival. Photo Credit: Phoonsab Thevongsa

That Luang festival returned to its pre-pandemic splendor this year, resulting in thousands of people from across the country and abroad flocking in to experience the festivities.

In N Out Storage stays bullish in self-storage business with new branch expansion

HONG KONG SAR – Media OutReach – 9 November 2022 – In N Out Storage, a Hong Kong based privately owned self-storage company, casts its vote of confidence in the City’s self-storage sector with its latest expansion into Tin Hau. Operates mostly with self-owned properties, this is the fourth expansion in 2022 following the opening of the San Po Kong branch in August.

The Tin Hau branch provides one hundred storage units that are accessible 24/7. In N Out’s existing portfolio of nine storage locations and over twenty storage facilities spans across Hong Kong Island and Kowloon with locations in Aberdeen, Sai Wan, Tin Hau, Chai Wan, Siu Sai Wan, Mong Kok, Hung Hom, Lai Chi Kok and San Po Kong. In N Out Storage’s sales has surged over 80% despite the pandamic and has grown to provide over 2500 storage units comprising of more than 150,000 square feet of property space across the City.

Addressing the booming demand of fine wine storage, In N Out Storage has newly revamped its facilities to cater wine collectors’ need through dedicated wine storage. Facilities are safeguarded with state of the art facial recognition security technology alongside stringent temperature and humidity control,

“Self-storage is a competitive business by nature. We have to be strategic in selecting expansion location .” said Jun Jun Lau, founder of In N Out Storage. ” We believe self-storage is not just a business but also a value-added service that would help the community to ease the shortage of living space. We continue to be optimistic in the growth of the sector and will continue to invest our resources into opening new stores and locations.”

Founded in 2015, In N Out Storage provides a variety of professional storage services, specializing in self-storage, wine storage, document storage and mailbox services. The Company aims to expand its storage network to better serve customers in Kowloon and New Territories in the near future.

Hashtag: #InNOutStorage

The issuer is solely responsible for the content of this announcement.